Skip to content

Relay Therapeutics, Inc. RLAY Investment Purchases

Investment Purchases at other companies

Celcuity logo
CelcuityCELC
$15.2M-64.2%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$222.18M+274%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$81.17M+13.6%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$52.67M
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$192.76M-38.0%
ALN
Alnylam PharmaceuticalsALNY
$261.63M-34.9%

Other financials

Income statement

See full
Revenue$3.0M-60.9%
Operating income-$78.6M+7.4%
Net income-$73.3M+4.9%
EPS (diluted)-$0.41+10.9%

Balance sheet

See full
Cash & equivalents$204.6M+119%
Total debt$31.6M-33.1%
Total equity$642.2M-10.9%
Total assets$699.6M-12.5%

Cash flow

See full
Operating cash flow-$51.1M+30.2%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$3.46B+300%
Enterprise value$3.29B+304%
P/S324.1×+212×

Profitability

See full
Operating margin-2,776.6%-820pp
Net margin-2,554.1%-745pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-40%-4.3pp
Debt / equity0.0×
Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s investment purchases?
Relay Therapeutics, Inc. (RLAY) reported investment purchases of $50.9M in Q1 2026.
How has Relay Therapeutics, Inc.'s investment purchases changed year-over-year?
Relay Therapeutics, Inc.'s investment purchases increased by 131.7% year-over-year, from $21.97M to $50.9M.
What is the long-term trend for Relay Therapeutics, Inc.'s investment purchases?
Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s investment purchases has grown at a -40.5% compound annual growth rate (CAGR), from $980.67M to $122.97M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.